2m 2m 2m 2m 2m 2m 2m
TREVI THERAPEUTI (TRVI)
NASDAQ
$14.47-$2.05 (-12.43%)
Price as of Jul 14, 2026 4:16 AM EDT- $2.5BMarket Cap
- 135.66%1-Year Change
- BiotechnologyIndustry
TREVI THERAPEUTI (TRVI)
$14.47-$2.05 (-12.43%)
TRVI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.52 | ||
Change | -$1.32 (-7.40%) | ||
Open | $17.73 | ||
High | $17.74 | ||
Low | $16.36 | ||
Previous Close | $17.84 | ||
Volume | 4,239,020 | ||
30-Day Average Volume | 3,106,980 | ||
1-Week Change | -7.97% | ||
1-Month Change | 16.26% | ||
1-Year Change | 135.66% | ||
3-Year Change | 640.81% | ||
5-Year Change | 717.82% | ||
Fundamentals | |||
Shares Outstanding | 142.0M | ||
Total Assets | $179.6M | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.2M | ||
Free Cash Flow | -$16.8M | ||
EBIT | -$13.2M | ||
EBITDA | -$13.2M | ||
Net Working Capital | $169.0M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -191 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -198 | ||
PEG | 3 | ||
Price/Free Cash Flow | -151 | ||
Price/Operating Cash Flow | -152 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue